InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score48
United States Fiscal year ends December CIK 0001787306 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

47
Insider
Date
Role
Action
Shares
Price
Amount
Masaru Matsuda
4 Nov 2026
EVP, Chief Legal Officer
Sold after exercise
40,000
$34.32
$1.37M
Howard G. Welgus
15 Oct 2026
Director
Sold after exercise
4,728
$26.93
$127.33K
Howard G. Welgus
15 Sep 2026
Director
Sold after exercise
4,730
$24.18
$114.37K
Terrie Curran
27 Aug 2026
Director
Sold after exercise
27,052
$25.03
$677.10K
Terrie Curran
27 Aug 2026
Director
Sold after exercise
11,148
$25.03
$279.03K
Terrie Curran
20 Aug 2026
Director
Sold after exercise
1,072
$26.04
$27.91K
Howard G. Welgus
17 Aug 2026
Director
Sold after exercise
4,730
$26.18
$123.83K
Patrick Burnett
12 Aug 2026
See Remarks
Sold after exercise
6,700
$26.08
$174.77K
Patrick Burnett
11 Aug 2026
See Remarks
Sold after exercise
8,300
$26.52
$220.13K
Howard G. Welgus
15 Jul 2026
Director
Sold after exercise
4,730
$26.91
$127.28K
Howard G. Welgus
15 Jun 2026
Director
Sold after exercise
4,096
$24.41
$99.98K
Keith R Leonard
2 Mar 2026
Director
Sold after exercise
39,272
$25.39
$997.19K
Patrick Burnett
15 Dec 2025
See Remarks
Sold after exercise
11,500
$28.94
$332.85K
Sue-Jean Lin
24 Nov 2025
Director
Sold after exercise
25,272
$30.78
$777.96K
Halley E Gilbert
20 Nov 2025
Director
Sold after exercise
16,532
$27.55
$455.44K
Neha Krishnamohan
13 Nov 2025
Director
Sold after exercise
1,232
$23.37
$28.79K
Neha Krishnamohan
13 Nov 2025
Director
Sold after exercise
39,272
$23.19
$910.70K
Patrick Burnett
6 Nov 2025
See Remarks
Sold after exercise
17,250
$24.18
$417.14K
Howard G. Welgus
1 Oct 2025
Director
Sold after exercise
462
$18.92
$8.74K
Howard G. Welgus
1 Oct 2025
Director
Sold after exercise
9,538
$18.92
$180.48K
Howard G. Welgus
2 Sep 2025
Director
Sold after exercise
10,000
$15.64
$156.38K
Howard G. Welgus
1 Aug 2025
Director
Sold after exercise
3,890
$14.30
$55.62K
Howard G. Welgus
1 Aug 2025
Director
Sold after exercise
6,110
$14.30
$87.36K
Patrick Burnett
14 Jul 2025
See Remarks
Sold after exercise
5,750
$15.07
$86.65K
Patrick Burnett
10 Jul 2025
See Remarks
Sold after exercise
23,000
$15.05
$346.05K
Patrick Burnett
14 Mar 2025
See Remarks
Sold after exercise
12,242
$15.04
$184.11K
Patrick Burnett
13 Mar 2025
See Remarks
Sold after exercise
5,008
$15.10
$75.63K
Patrick Burnett
13 Mar 2025
See Remarks
Sold after exercise
44,153
$14.97
$660.77K
Patrick Burnett
22 Nov 2024
See Remarks
Sold after exercise
16,023
$10.14
$162.51K
Patrick Burnett
15 Nov 2024
See Remarks
Sold after exercise
100
$10.03
$1.00K
Patrick Burnett
14 Nov 2024
See Remarks
Sold after exercise
18,377
$10.29
$189.18K
Patrick Burnett
14 Nov 2024
See Remarks
Sold after exercise
50,749
$10.29
$522.44K
Howard G. Welgus
1 Aug 2024
Director
Sold after exercise
3,386
$9.87
$33.42K
Howard G. Welgus
1 Aug 2024
Director
Sold after exercise
6,614
$9.87
$65.28K
Howard G. Welgus
1 Jul 2024
Director
Sold after exercise
10,000
$9.31
$93.14K
Howard G. Welgus
4 Jun 2024
Director
Sold after exercise
6,458
$8.01
$51.76K
Howard G. Welgus
4 Jun 2024
Director
Sold after exercise
3,542
$8.00
$28.34K
Patrick Burnett
30 May 2024
See Remarks
Sold after exercise
23,000
$8.75
$201.32K
Howard G. Welgus
17 Apr 2023
Director
Sold after exercise
8,500
$13.97
$118.73K
Howard G. Welgus
6 Apr 2023
Director
Sold after exercise
8,500
$12.01
$102.09K
Howard G. Welgus
15 Feb 2023
Director
Sold after exercise
8,500
$16.98
$144.35K
Howard G. Welgus
17 Jan 2023
Director
Sold after exercise
8,500
$13.72
$116.65K
Howard G. Welgus
15 Nov 2022
Director
Sold after exercise
3,403
$20.01
$68.10K
Todd Watanabe
5 Aug 2022
President and CEO
Sold after exercise
2,500
$24.74
$61.86K
Todd Watanabe
8 Jul 2022
President and CEO
Sold after exercise
7,087
$25.41
$180.11K
Todd Watanabe
8 Jul 2022
President and CEO
Sold after exercise
4,913
$25.41
$124.86K
Todd Watanabe
8 Jul 2022
President and CEO
Sold after exercise
1,500
$25.00
$37.50K
Showing 250 of 407 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 397
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 126
Sales straight out of an exercise 112
Sales at will 110
Transactions with no price 0
Shares from compensation/vesting 37,290,752
Sales filed before the plan box existed 97
History held since 3 Feb 2020